Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases (Q39644572)

13 September 2017

title

Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases (English)

1 reference

13 September 2017

1 reference

10

Isaiah J Fidler

1 reference

13 September 2017

Hisanori Uehara

1

1 reference

13 September 2017

Sun Jin Kim

2

1 reference

13 September 2017

Takashi Karashima

3

1 reference

13 September 2017

David L Shepherd

4

1 reference

13 September 2017

Dominic Fan

5

1 reference

13 September 2017

Rachel Tsan

6

1 reference

13 September 2017

Jerald J Killion

7

1 reference

13 September 2017

Christopher Logothetis

8

1 reference

13 September 2017

Paul Mathew

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of the National Cancer Institute

13 September 2017

published in

1 reference

13 September 2017

volume

95

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

458-470

1 reference

Spread of prostatic cancer to bone

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Modulation of the organ microenvironment for treatment of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Angiogenesis inhibition: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

The biology of platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

A role of PDGFRalpha in basal cell carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

New-age drug meets resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

The seed and soil hypothesis: vascularisation and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Endothelium-derived factors as paracrine mediators of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor beta and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.6.458

Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1023/A:1007189828584

Identifiers

DOI

10.1093/JNCI/95.6.458

1 reference

13 September 2017

1 reference